Article
SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma
25 Jun 2021
Abstract excerpt
Abstract Purpose It is of obvious interest to identify clinical prognosis-related oncogenes in HNSCC (head and neck squamous cell carcinoma). Methods Based on the available datasets within the TCGA (The Cancer Genome Atlas) and the GEO (Gene Expression Omnibus) databases, the potential mechanism of action of the SEC61G (SEC61 translocon subunit gamma) gene in HNSCC tumorigenesis was explored by several...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
